Skip to content

Clinical trials

Hypoparathyroidism trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoparathyroidism Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20171
20182
20192
20201
20211
20221
20232
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting3
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire4
Calcilytix Therapeutics, Inc., a BridgeBio company3
Alexion Pharmaceuticals, Inc.1
Ascendis Pharma A/S1
Ascendis Pharma Bone Diseases A/S1
Chugai Pharmaceutical1
MBX Biosciences1
Takeda1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoparathyroidism14
Endocrine System Diseases3
Hypocalcemia3
Parathyroid Diseases3
Calcium Metabolism Disorders2
Hypercalciuria2
Metabolic Diseases2
Muscular Diseases2
Musculoskeletal Abnormalities2
Musculoskeletal Diseases2

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.